Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart&#xA0;Failure and Use of Renin-Angiotensin System Antagonists

Heart Failure

Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists

J Am Coll Cardiol.

Ambrosy AP, Braunwald E, Morrow DA, DeVore AD, McCague K, Meng X, Duffy CI, Rocha R, Velazquez EJ, PIONEER-HF Investigators.

doi: 10.1016/j.jacc.2020.06.073.

Heart FailureHypertension

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The Multi-Ethnic Study of Atherosclerosis

Am J Hypertens.

Akhabue E, Vu TT, Vaidya A, Michos ED, de Boer IH, Kestenbaum B, Allison M, Szklo M, Ouyang P, Yancy CW, Wolf M, Isakova T, Carnethon MR

doi: 10.1093/ajh/hpy142.

Heart Failure

Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care

Heart

Desai RJ, Patorno E, Vaduganathan M, Mahesri M, Chin K, Levin R, Solomon SD, Schneeweiss S

doi: 10.1136/heartjnl-2021-319405

RECOMMENDED

Heart Failure

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

N Engl J Med.

Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP, PARAGON-HF Investigators and Committees.

doi: 10.1056/NEJMoa1908655.

Heart Failure

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors

Eur Heart J.

Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, Rienstra M, Friedrich AW, Samani NJ, Ng LL, Dickstein K, Lang CC, Filippatos G, Anker SD, Ponikowski P, Metra M, van Veldhuisen DJ, Voors AA

doi: 10.1093/eurheartj/ehaa373.

Heart Failure

Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure

JAMA Cardiol.

Oatmen KE, Zile MR, Burnett JC Jr, Spinale FG

doi: 10.1001/jamacardio.

Heart FailureHypertension

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.

JAMA Cardiol.

Desai AS, Vardeny O, Claggett B, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Zile MR, Lefkowitz M, Shi V, Solomon SD

doi: 10.1001/jamacardio.

Heart Failure

Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis

Eur J Heart Fail.

Segar MW, Patel KV, Ayers C, Basit M, Tang WHW, Willett D, Berry J, Grodin JL, Pandey A

doi: 10.1002/ejhf.1621.

Hypertension

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers

Hypertension.

Danser AHJ, Epstein M, Batlle D

doi: 10.1161/HYPERTENSIONAHA.

Related content

Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The Multi-Ethnic Study of Atherosclerosis

Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors

Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.

Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers